GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » TFBS Bioscience Inc (ROCO:6939) » Definitions » Total Stockholders Equity

TFBS Bioscience (ROCO:6939) Total Stockholders Equity : NT$1,232.7 Mil (As of Dec. 2024)


View and export this data going back to 2023. Start your Free Trial

What is TFBS Bioscience Total Stockholders Equity?

TFBS Bioscience's Total Stockholders Equity for the quarter that ended in Dec. 2024 was NT$1,232.7 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. TFBS Bioscience's Book Value per Share for the quarter that ended in Dec. 2024 was NT$35.28. The ratio of a company's debt over equity can be used to measure how leveraged this company is. TFBS Bioscience's Debt-to-Equity for the quarter that ended in Dec. 2024 was 0.16.

TFBS Bioscience Total Stockholders Equity Historical Data

The historical data trend for TFBS Bioscience's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

TFBS Bioscience Total Stockholders Equity Chart

TFBS Bioscience Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24
Total Stockholders Equity
247.95 424.86 1,237.22 1,260.61 1,232.72

TFBS Bioscience Semi-Annual Data
Dec20 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Total Stockholders Equity Get a 7-Day Free Trial 1,237.22 1,256.88 1,260.61 1,245.34 1,232.72

TFBS Bioscience  (ROCO:6939) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

TFBS Bioscience's Book Value per Share for the quarter that ended in Dec. 2024 is

Book Value per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(1232.722-0)/34.939
=35.28

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

TFBS Bioscience's Debt-to-Equity for the quarter that ended in Dec. 2024 is

Debt-to-Equity=Total Debt / Total Stockholders Equity
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Stockholders Equity
=(119.779 + 76.379) / 1232.722
=0.16

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

TFBS Bioscience Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of TFBS Bioscience's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

TFBS Bioscience Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » TFBS Bioscience Inc (ROCO:6939) » Definitions » Total Stockholders Equity
Comparable Companies
ROCO:6615 ROCO:7595 ROCO:6661 TPE:6645 ROCO:6847 ROCO:4160 ROCO:4153 ROCO:1784 TMO DHR XSWX:LONN IDXX A SHSE:603259 IQV MTD NTRA WAT LH DGX
Traded in Other Exchanges
N/A
Address
No. 103, Lane 169, Kang-ning Street, 3rd Floor, Xizhi District, New Taipei, TWN
Website
https://www.tfbsbio.com
TFBS Bioscience Inc is a Contract Research Organization (CRO) providing biological testing in Taiwan. Its services include viral vector manufacturing for cell and gene therapy products and biosafety testing and product release testing for cell and gene therapy products, vaccines, and biologic products.

TFBS Bioscience Headlines

No Headlines